undamentalytics Newsletter

Nutriband Inc. income statement

In fiscal 2026, Nutriband Inc. reported revenue of $2.0m, down 4.8% on the year before, operating income of −$8.3m (a -408.4% margin) and net income of −$8.2m, or −$2.58 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Nutriband Inc.: income statement, annual
Fiscal year2019Jan 20192020Jan 20202021Jan 20212022Jan 20222023Jan 20232024Jan 20242025Jan 20252026Jan 2026LTMJul 2026
Revenue001122222
Cost of revenue011111111
Gross profit−0−00111111
Research and development———012321
Selling, general and administrative323444476
Operating income−3−2−3−6−4−5−10−8−7
Interest expense—00000000
Income before tax−3−3−3−6−4−5−10−8−7
Net income−3−3−3−6−4−5−10−8−7
Diluted EPS−$0.62−$0.50−$0.51−$0.80−$0.53−$0.69−$0.99−$2.58−$0.57
Diluted shares (average)5m5m6m8m8m8m11m12m12m
EBITDA−3−2−2−6−4−5−10−8−7

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: LPCN vs NTRBNTRB vs SXTCNTRB vs SXTPEYPT vs NTRB

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Nutriband Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Nutriband Inc.